Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2]

Dec 1, 2025 · Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called …

Dec 11, 2024 · Imatinib (brand names Gleevec [oral tablet], Imkeldi [oral solution]) is used to treat certain types of leukemia (blood cancer), bone marrow disorders, and skin cancer. Imatinib is …

Feb 13, 2025 · Find patient medical information for Imatinib (Gleevec, Imkeldi) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

What is this medication? IMATINIB (i MAT in ib) treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread …

Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein in cancer cells. This helps slow or stop the spread of cancer cells. How …

This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Dec 12, 2022 · Imatinib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, …

What Is Imatinib and How Does It Work?

Apr 20, 2025 · Imatinib is a small molecule kinase inhibitor. Imatinib mesylate film-coated tablets are supplied as 100 mg and 400 mg tablets for oral administration. Each 100 mg tablet …